Related Experiment Video
Updated: Nov 1, 2025

Adapting 3' Rapid Amplification of CDNA Ends to Map Transcripts in Cancer
Published on: March 28, 2018
Cancer cell adaptability: turning ribonucleoprotein granules into targets
Margot Lavalée1, Nicolas Curdy1, Camille Laurent2
1Cancer Research Center of Toulouse (CRCT), Institut National de la Santé et de la Recherche Médicale (INSERM) Unité Mixte de Recherche (UMR) 1037, Centre National de la Recherche Scientifique (CNRS) UMR 5071, 31037 Toulouse, France; Université Toulouse III Paul Sabatier, 31330 Toulouse, France; Institut Universitaire du Cancer de Toulouse-Oncopole, 31100 Toulouse, France.
Stress granules and processing bodies are cellular condensates crucial for cancer cell survival and adaptation. Understanding their role in tumorigenesis could lead to novel cancer therapeutics targeting these ribonucleoprotein granules.
Area of Science:
- Cell Biology
- Cancer Biology
- Molecular Oncology
Background:
- Stress granules (SGs) and processing bodies (P-bodies) are key membraneless cytoplasmic condensates composed of ribonucleoproteins (RNPs).
- These RNP granules play critical roles in regulating RNA fate and maintaining cellular integrity under various conditions.
- Cancer cells exploit SGs and P-bodies to survive in the tumor microenvironment and resist therapies.
Purpose of the Study:
- To review the multifaceted roles of RNP granules in cancer biology.
- To explore how the composition and regulation of these granules can be leveraged for developing cancer therapeutic strategies.
Main Methods:
- Literature review focusing on RNP granule function in cancer.
- Analysis of current research on RNP granule composition and regulation in tumorigenesis.
- Synthesis of information to identify therapeutic potential.
Main Results:
- RNP granules are essential for cancer cell adaptation, survival, and resistance to treatment.
- Dysregulation of RNP granule dynamics is a hallmark of cancer.
- Specific RNP granule components and regulatory mechanisms are implicated in tumor progression.
Conclusions:
- RNP granules represent promising therapeutic targets in oncology.
- Further research into the biology of SGs and P-bodies is crucial for clinical applications in cancer therapy.
- Targeting RNP granule pathways offers a potential strategy to enhance the efficacy of existing cancer treatments.
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Treatment Resistant Cancers
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Nucleolus
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...

